These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 29264365)

  • 1. Nebulised antibiotherapy: conventional versus nanotechnology-based approaches, is targeting at a nano scale a difficult subject?
    de Pablo E; Fernández-García R; Ballesteros MP; Torrado JJ; Serrano DR
    Ann Transl Med; 2017 Nov; 5(22):448. PubMed ID: 29264365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nebuliser performance, pharmacokinetics, airways and systemic effects of salbutamol given via a novel nebuliser delivery system ("Ventstream").
    Newnham DM; Lipworth BJ
    Thorax; 1994 Aug; 49(8):762-70. PubMed ID: 8091320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhaled nano- and microparticles for drug delivery.
    El-Sherbiny IM; El-Baz NM; Yacoub MH
    Glob Cardiol Sci Pract; 2015; 2015():2. PubMed ID: 26779496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanosize drug delivery system.
    Mukherjee B
    Curr Pharm Biotechnol; 2013; 14(15):1221. PubMed ID: 25106648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nano- and micro-based inhaled drug delivery systems for targeting alveolar macrophages.
    Lee WH; Loo CY; Traini D; Young PM
    Expert Opin Drug Deliv; 2015 Jun; 12(6):1009-26. PubMed ID: 25912721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of nebulised antibiotic delivery in cystic fibrosis.
    Wilson D; Burniston M; Moya E; Parkin A; Smye S; Robinson P; Littlewood J
    Arch Dis Child; 1999 Apr; 80(4):348-52. PubMed ID: 10086942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Passive and Active Drug Targeting: Role of Nanocarriers in Rational Design of Anticancer Formulations.
    Das RP; Gandhi VV; Singh BG; Kunwar A
    Curr Pharm Des; 2019; 25(28):3034-3056. PubMed ID: 31470779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel nanoparticulate systems for lung cancer therapy: an updated review.
    Madni A; Batool A; Noreen S; Maqbool I; Rehman F; Kashif PM; Tahir N; Raza A
    J Drug Target; 2017 Jul; 25(6):499-512. PubMed ID: 28151021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nebulised delivery of RNA formulations to the lungs: From aerosol to cytosol.
    Neary MT; Mulder LM; Kowalski PS; MacLoughlin R; Crean AM; Ryan KB
    J Control Release; 2024 Feb; 366():812-833. PubMed ID: 38101753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nano-antibiotics in chronic lung infection therapy against Pseudomonas aeruginosa.
    Hadinoto K; Cheow WS
    Colloids Surf B Biointerfaces; 2014 Apr; 116():772-85. PubMed ID: 24656614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoparticulate-based drug delivery systems for small molecule anti-diabetic drugs: An emerging paradigm for effective therapy.
    Uppal S; Italiya KS; Chitkara D; Mittal A
    Acta Biomater; 2018 Nov; 81():20-42. PubMed ID: 30268916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanobiotechnology-based drug delivery in brain targeting.
    Dinda SC; Pattnaik G
    Curr Pharm Biotechnol; 2013; 14(15):1264-74. PubMed ID: 24910011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal Nanoparticulate Systems as Alternative Route of Drug Delivery.
    Alshweiat A; Ambrus R; Csoka I
    Curr Med Chem; 2019; 26(35):6459-6492. PubMed ID: 31453778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of nanotechnology in pharmaceutical product development.
    Devalapally H; Chakilam A; Amiji MM
    J Pharm Sci; 2007 Oct; 96(10):2547-65. PubMed ID: 17688284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanomedicine-based drug targeting for psoriasis: potentials and emerging trends in nanoscale pharmacotherapy.
    Rahman M; Akhter S; Ahmad J; Ahmad MZ; Beg S; Ahmad FJ
    Expert Opin Drug Deliv; 2015 Apr; 12(4):635-52. PubMed ID: 25439967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nano-carriers for the Treatment of Tuberculosis.
    Gilani SJ; Ameeduzzafar ; Jafar M; Shakil K; Imam SS
    Recent Pat Antiinfect Drug Discov; 2017; 12(2):95-106. PubMed ID: 28595544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances and Implications in Nanotechnology for Lung Cancer Management.
    Sarkar S; Osama K; Jamal QMS; Kamal MA; Sayeed U; Khan MKA; Siddiqui MH; Akhtar S
    Curr Drug Metab; 2017; 18(1):30-38. PubMed ID: 27842486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary deposition of nebulised pentamidine isethionate: effect of nebuliser type, dose, and volume of fill.
    O'Doherty M; Thomas S; Page C; Bradbeer C; Nunan T; Bateman N
    Thorax; 1990 Jun; 45(6):460-4. PubMed ID: 2392791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.